durvalumab,sorafenib,tremelimumab
astrazeneca,pfizer
['biomarker', 'himalaya', 'hcc', 'durva', 'arca ', 'arca, (-arcade)']
data from himalaya at #asco23: durvatreme in advanced #hcc: immune-related aes happen early (3 months) and are associated with longer os biomarker? could we identify these patients in advance? 
HPB and NET Medical Oncologist at @Hospital_FJD. Chair of @myESMO Media and Press Affairs WG. Chair of @EORTC Hepato-Biliary TF. #BiliaryCancer #HCC #NET #PDAC